retatrutide peotide Buy USA RETATRUTIDE (RETA) – Research Peptide

Indianapolis, IN: Eli Lilly and Co

Compounded products are not FDA-approved as finished drugs

The rates of invasive recurrence and metastatic disease were high in both groups, but the researchers found that people using GLP-1s had a 74% lower risk of invasive or metastatic cancer progression

World J Diabetes (2021) 12(6):74566

The glucose-dependent nature of GLP-1 and GIP receptor stimulation is an important safety feature, as these receptors stimulate insulin release primarily when blood glucose is already elevated

Acknowledgements Special thanks for all study team for their dedication and support in this study